Stereotaxis Stock
Stereotaxis Stock
Stereotaxis dominated the market today, gaining €0.12 (10.070%).
Pros and Cons of Stereotaxis in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Stereotaxis vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Stereotaxis | 10.070% | 0.162% | -20.972% | -35.625% | -36.939% | -9.781% | -83.629% |
| Cardiff Oncology Inc. | 3.170% | 16.643% | -27.329% | -62.748% | -67.052% | -47.123% | -80.945% |
| Electrocore Inc. | 0.000% | 1.961% | -29.252% | -10.345% | 36.126% | 41.825% | -57.965% |
| Lightpath Techs A | -2.750% | 26.829% | -18.750% | - | 16.201% | - | - |
News
Stereotaxis Q1 Earnings Call Highlights
Stereotaxis (NYSEAMERICAN:STXS) said its first-quarter results did not yet reflect what management described as a major commercial transition
